Skip to main content
Top
Published in: BMC Urology 1/2007

Open Access 01-12-2007 | Research article

In vivo MRI volumetric measurement of prostate regression and growth in mice

Authors: Kent L Nastiuk, Hui Liu, Mark Hamamura, L Tugan Muftuler, Orhan Nalcioglu, John J Krolewski

Published in: BMC Urology | Issue 1/2007

Login to get access

Abstract

Background
Mouse models for treatment of late-stage prostate cancer are valuable tools, but assessing the extent of growth of the prostate and particularly its regression due to therapeutic intervention or castration is difficult due to the location, small size and interdigitated anatomy of the prostate gland in situ. Temporal monitoring of mouse prostate regression requires multiple animals and examination of histological sections.

Methods

Initially, T2-weighted magnetic resonance imaging (MRI) was performed on normal year-old C57/BL6 mice. Individual mice were repeatedly imaged using inhalation anesthesia to establish the reproducibility of the method and to follow hormone manipulation of the prostate volume. Subsequently, MRI fat signal was suppressed using a chemical shift-selective (CHESS) pulse to avoid signal contamination and enhance discrimination of the prostate.

Results

High field (7T) MRI provides high resolution (117 × 117 μm in plane), highly reproducible images of the normal mouse prostate. Despite long imaging times, animals can be imaged repeatedly to establish reliability of volume measurements. Prostate volume declines following castration and subsequently returns to normal with androgen administration in the same animal. CHESS imaging allowed discrimination of both the margins of the prostate and the dorsal-lateral lobes of the prostate (DLP) from the ventral lobes (VP). Castration results in a 40% reduction in the volume of the DLP and a 75% reduction in the volume of the VP.

Conclusion

MRI assessment of the volume of the mouse prostate is precise and reproducible. MRI improves volumetric determination of the extent of regression and monitoring of the same mouse over time during the course of treatment is possible. Since assessing groups of animals at each time point is avoided, this improves the accuracy of the measurement of any manipulation effect and reduces the number of animals required.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kasper S, Smith JA: Genetically modified mice and their use in developing therapeutic strategies for prostate cancer. J Urol. 2004, 172: 12-19. 10.1097/01.ju.0000132122.93436.aa.CrossRefPubMed Kasper S, Smith JA: Genetically modified mice and their use in developing therapeutic strategies for prostate cancer. J Urol. 2004, 172: 12-19. 10.1097/01.ju.0000132122.93436.aa.CrossRefPubMed
2.
go back to reference Isaacs JT: Antagonistic effect of androgen on prostatic cell death. Prostate. 1984, 5: 545-557. 10.1002/pros.2990050510.CrossRefPubMed Isaacs JT: Antagonistic effect of androgen on prostatic cell death. Prostate. 1984, 5: 545-557. 10.1002/pros.2990050510.CrossRefPubMed
3.
go back to reference Denmeade SR, Lin XS, Isaacs JT: Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate. 1996, 28: 251-265. 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G.CrossRefPubMed Denmeade SR, Lin XS, Isaacs JT: Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate. 1996, 28: 251-265. 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G.CrossRefPubMed
4.
go back to reference Roy-Burman P, Wu H, Powell WC, Hagenkord J, Cohen MB: Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr Relat Cancer. 2004, 11: 225-254. 10.1677/erc.0.0110225.CrossRefPubMed Roy-Burman P, Wu H, Powell WC, Hagenkord J, Cohen MB: Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr Relat Cancer. 2004, 11: 225-254. 10.1677/erc.0.0110225.CrossRefPubMed
5.
go back to reference Xu S, Gade TP, Matei C, Zakian K, Alfieri AA, Hu X, Holland EC, Soghomonian S, Tjuvajev J, Ballon D, Koutcher JA: In vivo multiple-mouse imaging at 1.5 T. Magn Reson Med. 2003, 49: 551-557. 10.1002/mrm.10397.CrossRefPubMed Xu S, Gade TP, Matei C, Zakian K, Alfieri AA, Hu X, Holland EC, Soghomonian S, Tjuvajev J, Ballon D, Koutcher JA: In vivo multiple-mouse imaging at 1.5 T. Magn Reson Med. 2003, 49: 551-557. 10.1002/mrm.10397.CrossRefPubMed
6.
go back to reference Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, Pienta KJ, Greenberg NM, Zeng Z, Sanda MG: Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. J Urol. 1998, 160: 1500-1505. 10.1016/S0022-5347(01)62603-X.CrossRefPubMed Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, Pienta KJ, Greenberg NM, Zeng Z, Sanda MG: Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. J Urol. 1998, 160: 1500-1505. 10.1016/S0022-5347(01)62603-X.CrossRefPubMed
7.
go back to reference Song SK, Qu Z, Garabedian EM, Gordon JI, Milbrandt J, Ackerman JJ: Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Res. 2002, 62: 1555-1558.PubMed Song SK, Qu Z, Garabedian EM, Gordon JI, Milbrandt J, Ackerman JJ: Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Res. 2002, 62: 1555-1558.PubMed
8.
go back to reference Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H: Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A. 2001, 98: 10350-10355. 10.1073/pnas.171326098.CrossRefPubMedPubMedCentral Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H: Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A. 2001, 98: 10350-10355. 10.1073/pnas.171326098.CrossRefPubMedPubMedCentral
9.
go back to reference Garcia GE, Wisniewski HG, Lucia MS, Arevalo N, Slaga TJ, Kraft SL, Strange R, Kumar AP: 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6. Clin Cancer Res. 2006, 12: 980-988. 10.1158/1078-0432.CCR-05-2068.CrossRefPubMed Garcia GE, Wisniewski HG, Lucia MS, Arevalo N, Slaga TJ, Kraft SL, Strange R, Kumar AP: 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6. Clin Cancer Res. 2006, 12: 980-988. 10.1158/1078-0432.CCR-05-2068.CrossRefPubMed
10.
go back to reference Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg NM, Hsu CX, Sanda MG: Early castration reduces prostatic carcinogenesis in transgenic mice. Urology. 1999, 54: 1112-1119. 10.1016/S0090-4295(99)00297-6.CrossRefPubMed Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg NM, Hsu CX, Sanda MG: Early castration reduces prostatic carcinogenesis in transgenic mice. Urology. 1999, 54: 1112-1119. 10.1016/S0090-4295(99)00297-6.CrossRefPubMed
11.
go back to reference Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP: Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005, 436: 725-730. 10.1038/nature03918.CrossRefPubMedPubMedCentral Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP: Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005, 436: 725-730. 10.1038/nature03918.CrossRefPubMedPubMedCentral
12.
go back to reference Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C: In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate Cancer Models. Prostate. 2006, 66: 708-717. 10.1002/pros.20392.CrossRefPubMed Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C: In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate Cancer Models. Prostate. 2006, 66: 708-717. 10.1002/pros.20392.CrossRefPubMed
14.
go back to reference Banerjee PP, Banerjee S, Tilly KI, Tilly JL, Brown TR, Zirkin BR: Lobe-specific apoptotic cell death in rat prostate after androgen ablation by castration. Endocrinology. 1995, 136: 4368-4376. 10.1210/en.136.10.4368.PubMed Banerjee PP, Banerjee S, Tilly KI, Tilly JL, Brown TR, Zirkin BR: Lobe-specific apoptotic cell death in rat prostate after androgen ablation by castration. Endocrinology. 1995, 136: 4368-4376. 10.1210/en.136.10.4368.PubMed
15.
go back to reference Suwa T, Nyska A, Haseman JK, Mahler JF, Maronpot RR: Spontaneous lesions in control B6C3F1 mice and recommended sectioning of male accessory sex organs. Toxicol Pathol. 2002, 30: 228-234. 10.1080/019262302753559560.CrossRefPubMed Suwa T, Nyska A, Haseman JK, Mahler JF, Maronpot RR: Spontaneous lesions in control B6C3F1 mice and recommended sectioning of male accessory sex organs. Toxicol Pathol. 2002, 30: 228-234. 10.1080/019262302753559560.CrossRefPubMed
16.
go back to reference Hu Z, Ito T, Yuri K, Xie C, Ozawa H, Kawata M: In vivo time course of morphological changes and DNA degradation during the degeneration of castration-induced apoptotic prostate cells. Cell Tissue Res. 1998, 294: 153-160. 10.1007/s004410051165.CrossRefPubMed Hu Z, Ito T, Yuri K, Xie C, Ozawa H, Kawata M: In vivo time course of morphological changes and DNA degradation during the degeneration of castration-induced apoptotic prostate cells. Cell Tissue Res. 1998, 294: 153-160. 10.1007/s004410051165.CrossRefPubMed
17.
go back to reference Berges RR, Furuya Y, Remington L, English HF, Jacks T, Isaacs JT: Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci U S A. 1993, 90: 8910-8914. 10.1073/pnas.90.19.8910.CrossRefPubMedPubMedCentral Berges RR, Furuya Y, Remington L, English HF, Jacks T, Isaacs JT: Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci U S A. 1993, 90: 8910-8914. 10.1073/pnas.90.19.8910.CrossRefPubMedPubMedCentral
18.
go back to reference Suzuki A, Matsuzawa A, Iguchi T: Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene. 1996, 13: 31-37.PubMed Suzuki A, Matsuzawa A, Iguchi T: Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene. 1996, 13: 31-37.PubMed
19.
go back to reference Sugihara A, Yamada N, Tsujimura T, Iwasaki T, Yamashita K, Takagi Y, Tsuji M, Terada N: Castration induces apoptosis in the male accessory sex organs of Fas- deficient lpr and Fas ligand-deficient gld mutant mice. In Vivo. 2001, 15: 385-390.PubMed Sugihara A, Yamada N, Tsujimura T, Iwasaki T, Yamashita K, Takagi Y, Tsuji M, Terada N: Castration induces apoptosis in the male accessory sex organs of Fas- deficient lpr and Fas ligand-deficient gld mutant mice. In Vivo. 2001, 15: 385-390.PubMed
20.
go back to reference de la Taille A, Chen MW, Shabsigh A, Bagiella E, Kiss A, Buttyan R: Fas antigen/CD-95 upegulation and activation during castration-induced regression of the rat ventral prostate gland. Prostate. 1999, 40: 89-96. 10.1002/(SICI)1097-0045(19990701)40:2<89::AID-PROS4>3.0.CO;2-E.CrossRefPubMed de la Taille A, Chen MW, Shabsigh A, Bagiella E, Kiss A, Buttyan R: Fas antigen/CD-95 upegulation and activation during castration-induced regression of the rat ventral prostate gland. Prostate. 1999, 40: 89-96. 10.1002/(SICI)1097-0045(19990701)40:2<89::AID-PROS4>3.0.CO;2-E.CrossRefPubMed
Metadata
Title
In vivo MRI volumetric measurement of prostate regression and growth in mice
Authors
Kent L Nastiuk
Hui Liu
Mark Hamamura
L Tugan Muftuler
Orhan Nalcioglu
John J Krolewski
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2007
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/1471-2490-7-12

Other articles of this Issue 1/2007

BMC Urology 1/2007 Go to the issue